83.68
price up icon0.77%   0.64
after-market アフターアワーズ: 83.68
loading
前日終値:
$83.04
開ける:
$84.6
24時間の取引高:
5.60M
Relative Volume:
1.08
時価総額:
$48.18B
収益:
$6.30B
当期純損益:
$1.07B
株価収益率:
45.46
EPS:
1.8406
ネットキャッシュフロー:
$1.09B
1週間 パフォーマンス:
-1.03%
1か月 パフォーマンス:
-7.82%
6か月 パフォーマンス:
+2.22%
1年 パフォーマンス:
+6.61%
1日の値動き範囲:
Value
$83.22
$85.51
1週間の範囲:
Value
$81.16
$89.08
52週間の値動き範囲:
Value
$72.30
$96.29

Edwards Lifesciences Corp Stock (EW) Company Profile

Name
名前
Edwards Lifesciences Corp
Name
セクター
Healthcare (1076)
Name
電話
(949) 250-2500
Name
住所
ONE EDWARDS WAY, IRVINE, CA
Name
職員
16,000
Name
Twitter
@edwardslifesci
Name
次回の収益日
2026-07-23
Name
最新のSEC提出書
Name
EW's Discussions on Twitter

Compare EW vs ABT, SYK, MDT, BSX

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
EW icon
EW
Edwards Lifesciences Corp
83.68 47.81B 6.30B 1.07B 1.09B 1.8406
ABT icon
ABT
Abbott Laboratories
107.27 182.00B 46.59B 5.41B 7.38B 3.0938
SYK icon
SYK
Stryker Corp
346.60 129.09B 25.27B 3.34B 4.57B 8.6334
MDT icon
MDT
Medtronic Plc
86.88 107.81B 36.36B 4.84B 5.43B 3.7261
BSX icon
BSX
Boston Scientific Corp
46.06 67.64B 20.62B 3.56B 3.48B 2.3847

Edwards Lifesciences Corp Stock (EW) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-04-01 アップグレード Wolfe Research Peer Perform → Outperform
2026-01-09 アップグレード TD Cowen Hold → Buy
2025-12-18 アップグレード JP Morgan Neutral → Overweight
2025-11-03 アップグレード Raymond James Mkt Perform → Outperform
2025-10-29 アップグレード Jefferies Hold → Buy
2025-10-29 アップグレード Wolfe Research Underperform → Peer Perform
2025-10-08 ダウングレード Oppenheimer Outperform → Perform
2025-10-07 アップグレード Evercore ISI In-line → Outperform
2025-07-29 アップグレード BTIG Research Neutral → Buy
2025-04-24 アップグレード Piper Sandler Neutral → Overweight
2025-01-30 アップグレード Stifel Hold → Buy
2025-01-16 ダウングレード Wolfe Research Peer Perform → Underperform
2024-12-16 アップグレード BofA Securities Neutral → Buy
2024-10-11 再開されました Morgan Stanley Equal-Weight
2024-09-18 ダウングレード Jefferies Buy → Hold
2024-07-31 アップグレード Daiwa Securities Neutral → Outperform
2024-07-29 アップグレード Wolfe Research Underperform → Peer Perform
2024-07-25 ダウングレード BofA Securities Buy → Neutral
2024-07-25 ダウングレード JP Morgan Overweight → Neutral
2024-07-25 ダウングレード Robert W. Baird Outperform → Neutral
2024-07-25 ダウングレード TD Cowen Buy → Hold
2024-07-25 ダウングレード Truist Buy → Hold
2024-05-30 開始されました Goldman Buy
2024-05-22 アップグレード Citigroup Neutral → Buy
2024-05-14 アップグレード Deutsche Bank Hold → Buy
2024-03-07 アップグレード BofA Securities Neutral → Buy
2024-02-02 アップグレード Wells Fargo Equal Weight → Overweight
2024-01-04 ダウングレード Evercore ISI Outperform → In-line
2023-12-11 ダウングレード Citigroup Buy → Neutral
2023-11-28 ダウングレード Wolfe Research Peer Perform → Underperform
2023-09-26 アップグレード Oppenheimer Perform → Outperform
2023-07-19 開始されました Robert W. Baird Outperform
2023-05-30 再開されました Morgan Stanley Overweight
2023-03-29 開始されました UBS Neutral
2023-03-08 ダウングレード Wells Fargo Overweight → Equal Weight
2023-02-06 ダウングレード Raymond James Outperform → Mkt Perform
2023-01-31 ダウングレード Bernstein Outperform → Underperform
2023-01-30 ダウングレード Piper Sandler Overweight → Neutral
2022-12-06 ダウングレード Stifel Buy → Hold
2022-10-28 ダウングレード Oppenheimer Outperform → Perform
2022-10-26 開始されました Mizuho Buy
2022-10-18 開始されました Barclays Overweight
2022-10-12 開始されました Jefferies Buy
2022-07-29 ダウングレード Canaccord Genuity Buy → Hold
2022-04-13 開始されました Truist Buy
2022-04-06 開始されました Wolfe Research Outperform
2022-03-16 アップグレード Bernstein Mkt Perform → Outperform
2022-03-02 再開されました BofA Securities Neutral
2022-02-02 アップグレード UBS Neutral → Buy
2022-01-27 繰り返されました Citigroup Buy
2022-01-27 繰り返されました Evercore ISI Outperform
2022-01-27 繰り返されました Raymond James Outperform
2022-01-27 繰り返されました Stifel Buy
2022-01-27 繰り返されました UBS Neutral
2021-12-17 アップグレード JP Morgan Neutral → Overweight
2021-12-15 アップグレード Citigroup Neutral → Buy
2021-12-10 開始されました RBC Capital Mkts Outperform
2021-12-06 アップグレード Wells Fargo Equal Weight → Overweight
2021-07-30 繰り返されました Canaccord Genuity Buy
2021-07-30 繰り返されました Deutsche Bank Hold
2021-07-30 繰り返されました Jefferies Buy
2021-07-30 繰り返されました Morgan Stanley Overweight
2021-07-30 繰り返されました Oppenheimer Outperform
2021-07-30 繰り返されました Stifel Buy
2021-07-30 繰り返されました UBS Neutral
2021-07-30 繰り返されました Wells Fargo Equal Weight
2021-05-25 開始されました Barclays Overweight
2021-04-15 開始されました Atlantic Equities Neutral
2021-04-05 アップグレード Evercore ISI In-line → Outperform
2020-12-16 ダウングレード Citigroup Buy → Neutral
2020-12-11 繰り返されました Canaccord Genuity Buy
2020-09-11 開始されました Wolfe Research Underperform
2020-04-28 ダウングレード Wells Fargo Overweight → Equal Weight
2020-04-17 アップグレード SVB Leerink Mkt Perform → Outperform
2020-03-05 開始されました Citigroup Buy
2020-02-13 開始されました Goldman Neutral
2020-02-06 再開されました BTIG Research Neutral
2020-01-10 開始されました Oppenheimer Outperform
2020-01-02 ダウングレード Evercore ISI Outperform → In-line
2019-10-24 繰り返されました Canaccord Genuity Buy
2019-09-23 開始されました Piper Jaffray Overweight
2019-07-24 繰り返されました BofA/Merrill Buy
2019-03-18 繰り返されました Canaccord Genuity Buy
2019-01-18 アップグレード BofA/Merrill Neutral → Buy
2019-01-03 開始されました Deutsche Bank Hold
2018-11-28 開始されました UBS Neutral
2018-10-16 開始されました Barclays Underweight
2018-10-02 ダウングレード BofA/Merrill Buy → Neutral
2018-10-02 ダウングレード Guggenheim Buy → Neutral
すべてを表示

Edwards Lifesciences Corp (EW) 最新ニュース

pulisher
Jul 28, 2026

UBS initiates Edwards Lifesciences stock coverage with buy rating By Investing.com - Investing.com Canada

Jul 28, 2026
pulisher
Jul 27, 2026

Form 4 Edwards Lifesciences Corp For: 27 July By Investing.com - Investing.com Nigeria

Jul 27, 2026
pulisher
Jul 27, 2026

Edwards Lifesciences CEO Bernard Zovighian sells $245,134 in shares - Investing.com

Jul 27, 2026
pulisher
Jul 27, 2026

Form 144 Edwards Lifesciences Corp For: 27 July By Investing.com - Investing.com South Africa

Jul 27, 2026
pulisher
Jul 27, 2026

Form 144 Edwards Lifesciences Corp For: 27 July - Investing.com India

Jul 27, 2026
pulisher
Jul 27, 2026

EW|Edwards Lifesciences Corp|Price:83.040|Chg%:+0.410 - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Edwards Lifesciences (EW)’s TMTT Revenue Surges 47%: Can Rapid Growth Drive the Next Leg of Earnings Expansion? - Yahoo Finance Singapore

Jul 27, 2026
pulisher
Jul 27, 2026

Edwards Lifesciences (EW) insider Zovighian details recent $2.83M stock sale in Form 144 - Stock Titan

Jul 27, 2026
pulisher
Jul 27, 2026

Edwards Lifesciences Corp (EW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 27, 2026
pulisher
Jul 26, 2026

Edwards Lifesciences stock trades steady as TAVR growth supports margins - Ad-hoc-news.de

Jul 26, 2026
pulisher
Jul 25, 2026

ETFs Investing in Edwards Lifesciences Corporation Stocks - TradingView

Jul 25, 2026
pulisher
Jul 25, 2026

Edwards Lifesciences (EW) Stock Looks Fair On Cash Flow While Earnings Trade At A Premium - Yahoo Finance

Jul 25, 2026
pulisher
Jul 24, 2026

Edwards Lifesciences Corp (EW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jul 24, 2026
pulisher
Jul 24, 2026

Edwards Lifesciences Corp (EW) Institutional Confidence - TradingKey

Jul 24, 2026
pulisher
Jul 24, 2026

EW|Edwards Lifesciences Corp|Price:82.630|Chg%:-1.185 - TradingKey

Jul 24, 2026
pulisher
Jul 24, 2026

Edwards Lifesciences Corp. stock underperforms Friday when compared to competitors - MarketWatch

Jul 24, 2026
pulisher
Jul 24, 2026

Edwards posts strong TAVR sales ahead of potential Medicare coverage expansion - MedTech Dive

Jul 24, 2026
pulisher
Jul 24, 2026

Why is Edwards Lifesciences stock rallying today? By Investing.com - Investing.com South Africa

Jul 24, 2026
pulisher
Jul 24, 2026

Why is Edwards Lifesciences stock rallying today? - Investing.com

Jul 24, 2026
pulisher
Jul 24, 2026

Bernstein raises Edwards Lifesciences stock price target on earnings beat - Investing.com

Jul 24, 2026
pulisher
Jul 24, 2026

Bernstein raises Edwards Lifesciences stock price target on earnings beat By Investing.com - Investing.com Canada

Jul 24, 2026
pulisher
Jul 24, 2026

Edwards Lifesciences (EW) Receives Upgrade from Leerink with New Price Target - GuruFocus

Jul 24, 2026
pulisher
Jul 24, 2026

Edwards Lifesciences Reports Strong Q2 2026 Results With 13.6% Sales Growth, Raises Full-Year Guidance - Minichart

Jul 24, 2026
pulisher
Jul 24, 2026

Piper Sandler raises Edwards Lifesciences stock price target on earnings beat - Investing.com

Jul 24, 2026
pulisher
Jul 24, 2026

Edwards lifts FY26 growth outlook following steady Q2 performance - Yahoo Finance

Jul 24, 2026
pulisher
Jul 24, 2026

Edwards Lifesciences Corporatio (EW) Stock Forecasts - Yahoo Finance

Jul 24, 2026
pulisher
Jul 24, 2026

Stock Market Today: S&P 500, Dow Jones, Nasdaq 100 Futures Gain as Oil Prices Decline—Intel, Edwards Life - Benzinga

Jul 24, 2026
pulisher
Jul 24, 2026

Edwards' Q2 Earnings & Revenues Top Estimates, Stock Rises - Yahoo Finance

Jul 24, 2026
pulisher
Jul 24, 2026

EDWARDS LIFESCIENCES CORP : LEERINK PARTNERS RAISES TO OUTPERFORM FROM MARKET PERFORM; RAISES TARGET PRICE TO $101 FROM $87 - Bitget

Jul 24, 2026
pulisher
Jul 24, 2026

Edwards Lifesciences Corporation Q2 2026 Earnings Call Summary - Yahoo Finance

Jul 24, 2026
pulisher
Jul 24, 2026

Bernstein Adjusts Price Target on Edwards Lifesciences to $99 From $96, Maintains Market Perform Rating - marketscreener.com

Jul 24, 2026
pulisher
Jul 24, 2026

Leerink upgrades Edwards Lifesciences stock rating on TAVR momentum - Investing.com

Jul 24, 2026
pulisher
Jul 24, 2026

Edwards Lifesciences stock holds focus on margin and growth - AD HOC NEWS

Jul 24, 2026
pulisher
Jul 24, 2026

Leerink upgrades Edwards Lifesciences stock rating on TAVR momentum By Investing.com - Investing.com Canada

Jul 24, 2026
pulisher
Jul 24, 2026

Leerink Partners Upgrades Edwards Lifesciences to Outperform From Market Perform, Adjusts PT to $101 From $87 - marketscreener.com

Jul 24, 2026
pulisher
Jul 24, 2026

EW|Edwards Lifesciences Corp|Price:83.800|Chg%:-0.570 - TradingKey

Jul 24, 2026
pulisher
Jul 24, 2026

Edwards Lifesciences Corp (EW) Q2 2026 Earnings Call Highlights: Strong Sales Growth and ... - Yahoo! Finance Canada

Jul 24, 2026
pulisher
Jul 24, 2026

Edwards Lifesciences Corp (EW) Q2 2026 Earnings Call Highlights: Strong Sales Growth and Strategic Advancements - GuruFocus

Jul 24, 2026
pulisher
Jul 23, 2026

Edwards Lifesciences Announces Q2 2026 Financial Results Highlighting Market Leadership - Kalkine Media

Jul 23, 2026
pulisher
Jul 23, 2026

Edwards Lifesciences (EW) Reports Strong Q2 2026 Sales Growth - GuruFocus

Jul 23, 2026
pulisher
Jul 23, 2026

Edwards Lifesciences Q2 Earnings Call Highlights - Yahoo Finance

Jul 23, 2026
pulisher
Jul 23, 2026

Edwards Lifesciences earnings up next: TAVR momentum in focus - Investing.com UK

Jul 23, 2026
pulisher
Jul 23, 2026

Earnings call transcript: Edwards Lifesciences tops Q2 2026 estimates, lifts sales outlook - Investing.com

Jul 23, 2026
pulisher
Jul 23, 2026

Edwards Lifesciences (EW) Reports Strong Q2 Earnings, Raises Rev - GuruFocus

Jul 23, 2026
pulisher
Jul 23, 2026

Edwards Lifesciences (EW) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance

Jul 23, 2026
pulisher
Jul 23, 2026

Edwards Lifesciences Corp reports results for the quarter ended June 30Earnings Summary - TradingView

Jul 23, 2026
pulisher
Jul 23, 2026

Edwards Lifesciences Jumps After Strong Q2 Growth and Higher 2026 Sales Outlook - Moomoo

Jul 23, 2026
pulisher
Jul 23, 2026

Edwards Lifesciences jumps after strong Q2 growth and higher 2026 sales outlook - Quiver Quantitative

Jul 23, 2026
pulisher
Jul 23, 2026

Edwards Lifesciences Narrows Full-Year Sales Outlook After Second-Quarter Growth - WSJ

Jul 23, 2026
pulisher
Jul 23, 2026

Is Edwards Lifesciences (EW) Undervalued After Q2 Earnings Beat? - GuruFocus

Jul 23, 2026
pulisher
Jul 23, 2026

Edwards Lifesciences Q2 Adjusted Earnings, Revenue Rise; Q3 Guidance Set - marketscreener.com

Jul 23, 2026

Edwards Lifesciences Corp (EW) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$64.11
price up icon 4.89%
$74.85
price up icon 2.02%
BSX BSX
$46.06
price up icon 1.21%
PHG PHG
$25.55
price up icon 2.12%
STE STE
$230.34
price up icon 5.47%
大文字化:     |  ボリューム (24 時間):